Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study

Intermittent hypoxia and various pharmacological compounds protect the heart from ischemia reperfusion injury in experimental approaches, but the translation into clinical trials has largely failed. One reason may lie in species differences and the lack of suitable human in vitro models to test for...

Descripción completa

Detalles Bibliográficos
Autores principales: Funcke, Sandra, Werner, Tessa R., Hein, Marc, Ulmer, Bärbel M., Hansen, Arne, Eschenhagen, Thomas, Hirt, Marc N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565486/
https://www.ncbi.nlm.nih.gov/pubmed/32932811
http://dx.doi.org/10.3390/biom10091309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565486/
https://www.ncbi.nlm.nih.gov/pubmed/32932811
http://dx.doi.org/10.3390/biom10091309

Ejemplares similares